Message #7 From:
Stock News Bot Date: December 15, 2006 07:32:00 AM
CPEU News Dutton Associates Announces Investment Opinion on BluePoint Energy
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--Dutton Associates continues its coverage of Chapeau, Inc. d/b/a
BluePoint Energy, Inc. (OTC BB: CPEU)
reiterating its rating of Strong Speculative Buy while increasing its
12-month price target to $2.40. The research note dated December 14,
2006 by Dutton senior analyst Richard West, CFA is available at www.jmdutton.com
as well as from First Call, Bloomberg, Zacks, Knobias, Reuters, and
other leading financial portals.
As set forth in the referenced report, both the recently announced
planned conversion of long-term debt and current fiscal year guidance
are major positives and most welcome at this stage in BluePoint Energy’s
development. Both events send signals to investors that BluePoint Energy’s
proprietary technology, combining cooling, heat and power (CCHP) modules
with ultra-clean emissions utilizing its EnviroGen™
equipment could be the spark that leads BluePoint Energy to become a
major player in the worldwide energy savings market. We reiterate our
rating of Strong Speculative Buy and are raising our 12-month price
target to $2.40 per share.
About Dutton Associates
Dutton Associates is one of the largest independent investment research
firms in the US. Its 31 senior analysts are primarily CFAs and have
expertise in many industries. Dutton Associates provides continuing
analyst coverage of over 140 enrolled companies, and its research,
estimates, and ratings are carried in all the major databases serving
institutions and online investors.
The cost of enrollment in our one-year continuing research program is US
$33,000 prepaid for 4 Research Reports, typically published quarterly,
and requisite Research Notes. Dutton Associates received $58,000 from
the Company for 8 Research Reports with coverage commencing on
7/09/2004. We do not accept payment of our fees in company stock. Our
principals and analysts are prohibited from owning or trading in
securities of covered companies. The views expressed in this research
report accurately reflect the analyst’s
personal views about the subject securities or issuer. Neither the
analyst’s compensation nor the compensation
received by us is in any way related to the specific ratings or views
contained in this research report or note. Please read full disclosures
and analyst background at www.jmdutton.com
before investing.
